week hiv - PowerPoint Presentations and PDF Documents

Lenacapavir with bNAbs

by skylar

. Teropavimab. (GS-5423) and . Zinlirvimab. (GS-...

CROI 2015: Treatment and Cure Highlights

by unita

Shireesha Dhanireddy. Robert Harrington. March 17,...

Genotype-directed dosing for

by bency

Efavirenz. . T. G MBENGERANWA. Harare Family Care...

Dolutegravir vs. Raltegravir

by zoe

SPRING-2 Study. Dolutegravir. versus Raltegravir....

ClinicalTrials.gov

by lauren

Identifier: . NCT02770508 . Dual therapy based on ...

Cabotegravir plus Rilpivirine

by jaxson809

Extended Release Injectable Suspension. Last Updat...

Modifying Therapy in the Treatment-experienced Patient:

by yoshiko-marsland

When should it be done?. Professor of Medicine. U...

1 Fundación Huésped, Buenos Aires, Argentina;

by aaron

2. Instituto Nacional de Ciencias Médicas y Nutr...

Fixed-Dose Combination of

by myesha-ticknor

Doravirine. /Lamivudine/TDF is Non-Inferior to . ...

International Health Elective:

by jane-oiler

National Pediatric Hospital. Phnom Penh, Cambodia...

PEG alfa-2a RBV versus

by alexa-scheidler

. PEG alfa-. 2a . versus. INF RBV . APRICOT S...

Dual ART: Entering a New Paradigm

by pamella-moone

Moderator. François Raffi, MD, PhD. Professor of...

Review of Non-Daily PrEP Clinical Research and Experience

by mitsue-stanley

Robert M. Grant, M.D., M.P.H. .. IAS 2017, July 2...

Peginterferon alfa-2a +

by stefany-barnette

RBV . versus. Interferon alfa. -. 2a + RBV . ACT...

[ INSERT ORGANISATION NAME

by lois-ondreau

] . Media . Evaluation Report. European HIV-Hepat...

Comparison of NRTI combinations

by tawny-fly

ZDV/3TC . vs. TDF + FTC. Study 934. ABC/3TC . vs...

PEG alfa-2a +

by tawny-fly

RBV . versus. . PEG alfa-. 2a . versus. INF + R...

A. D. Smith,

by pasty-toler

1. A. Muhaari . 2. E. M. van der Elst . 2. D. ...

Search Results for 'week hiv'